Nephrology Doctors in Pennsylvania Medicare Details, Address, Contact

513 Nephrology doctors found. Showing 61 - 80

Dr. Allen I Wolfert, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1597 Washington Pike, Suite A-22, Bridgeville, PA 15017 Phone: 412-489-6919    Fax: 412-489-6279

Miss Samantha I Torok, CRNP Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1597 Washington Pike Ste A22, Bridgeville, PA 15017 Phone: 412-489-6919    Fax: 412-489-6279

Dr. Qizhi Xie, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1597 Washington Pike, Suite A-22, Bridgeville, PA 15017 Phone: 412-489-6919    Fax: 412-489-6279

Alonso R Diaz, M. D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1597 Washington Pike Ste A22, Bridgeville, PA 15017 Phone: 412-489-6919    Fax: 412-489-6279

Dr. Sophia Moldavsky, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 830 Old Lancaster Rd Ste 206, Bryn Mawr, PA 19010 Phone: 610-525-8110

Dr. Anthony R. Zappacosta, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 830 Old Lancaster Rd, Suite 206, Bryn Mawr, PA 19010 Phone: 610-525-8110

Dr. Gregory Mark Closkey, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 830 Old Lancaster Rd, Suite 206, Bryn Mawr, PA 19010 Phone: 610-525-8110

Sanjeev Suri, M.D Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 202 W Diamond St, Butler, PA 16001 Phone: 724-431-0253    Fax: 724-431-0254

Mr. Amith Roy Shamir, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 111 Woody Dr, Butler, PA 16001 Phone: 724-287-1000    Fax: 724-548-1396

George Ezeji, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 205 Grandview Ave Ste 301, Camp Hill, PA 17011 Phone: 717-695-0394    Fax: 717-695-0398

Ms. Julie A Rothman, D.O. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 205 Grandview Ave, Suite 402, Camp Hill, PA 17011 Phone: 717-972-2800    Fax: 717-972-2845

Dr. Mohamed F Elnour, M.D., FASN Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 425 N 21st St, Suite 204, Camp Hill, PA 17011 Phone: 717-737-3377    Fax: 717-737-3387

Ms. Sangeeta Mital, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 207 House Ave Ste 110, Camp Hill, PA 17011 Phone: 717-972-2821    Fax: 717-972-2845

Kaushal R Patel, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 207 House Ave Ste 110, Camp Hill, PA 17011 Phone: 717-972-2821    Fax: 717-972-2845

Gerald B Martin, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 64 S West St, Carlisle, PA 17013 Phone: 717-245-2291    Fax: 717-245-9652

Dr. Stanley Francis Banach, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5401 Aberdene St, Center Valley, PA 18034 Phone: 610-282-2099

Kevin Sperling, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 601 Chadds Ford Drive, Suite 100, Chadds Ford, PA 19317 Phone: 610-388-0536    Fax: 610-388-0410

Awais Ammar, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 20 Parkwood Dr Ste 2, Chambersburg, PA 17201 Phone: 717-263-7757

Dr. May Christine Joy Sales Zeta, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 20 Parkwood Dr Ste 2, Chambersburg, PA 17201 Phone: 717-263-7757    Fax: 717-263-8376

Hafiz Zafar Ahmed Mahmood, M.D Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 20 Parkwood Dr Ste 2, Chambersburg, PA 17201 Phone: 717-263-8376

News Archive

Arrowhead, Axolabs enter into RNAi therapeutics strategic agreement

Arrowhead Research Corporation, a nanomedicine company with development programs in RNAi therapeutics and obesity, and Axolabs GmbH, a custom research organization offering preclinical solutions and consultancy in the field of oligonucleotide therapeutics, today announced that they have entered into a Strategic Alliance and Master Services Agreement.

If you want to avoid smoke-filled pubs you will be better off in the south of England

If you want to avoid smoke-filled pubs you will be better off in the south of England than in the north according to a snapshot survey published today by the British Medical Association (BMA). In an attempt to establish just how many pubs will be exempt from laws banning smoking in enclosed workplaces, the BMA found wide regional differences with a strong north-south divide.

Deep brain stimulation effective in resistant depression

A new study in the American Journal of Psychiatry says deep brain stimulation is an effective treatment in depressed patients who do not respond to other forms of therapy. The study published on October 4, 2019, looked at the long-term effects on patients who had received electrical stimulation to the subcallosal cingulate area of the brain. The subcallosal cingulate area of the brain is also called Brodmann Area 25, and has been targeted by researchers as a possible focus for antidepressant stimulation.

CTRC commences enrollment in Phase 2 trial of REOLYSIN combination for SCC lung cancer

A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.

New AstraZeneca compound shows promoise for hormone resistant prostate cancer patients with bone metastases

New Phase II data suggests that ZD4054, a novel compound in development for the treatment of men with Hormone Resistant Prostate Cancer (HRPC), could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »